IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Imprimis Pharmaceuticals Inc

Q4 2019 vs Q1 2020

Comparing institutional holders between quarters

Quarters

Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Opaleye Management Inc.
INCREASED
Shares2,500,000 from 2,340,000
Change+160,000 (+7%)
Value$9.6K (-$8.7K)
Filed 2020-05-15
Proequities, Inc.
UNCHANGED
Shares0 from 0
Change0
Value$0 ($0)
Filed 2020-05-13
Status
Opaleye Management Inc.
INCREASED2,500,0002,340,000+160,000+7%$18.2K$9.6K-$8.7K2020-05-15
Proequities, Inc.
UNCHANGED000—$0$0$02020-05-13
Showing 2 of 2 institutions